Chris Belt

Chris R. Belt serves as Deputy Director of the Office of Acquisitions at the National Heart, Lung, and Blood Institute (NHLBI), where he oversees the strategic planning and execution of federal procurement activities to support biomedical research and clinical diagnostics. In this role, he ensures compliance with federal acquisition regulations while aligning contracting strategies with NHLBI’s scientific mission. His portfolio encompasses complex scientific and technical services, laboratory instrumentation, and data infrastructure solutions critical to advancing cardiovascular, pulmonary, and blood disorder research. He plays a pivotal role in shaping acquisition policies that balance innovation, efficiency, and regulatory rigor across the institute’s procurement lifecycle. While specific contractor names are not publicly disclosed, Belt’s office maintains a broad network of vendors specializing in high-precision analytical equipment, scientific consulting, and IT-enabled research support services. His team engages with both large prime contractors and specialized small businesses to deliver mission-critical capabilities, emphasizing performance-based contracting and outcome-driven requirements. Vendor relationships are typically structured around long-term indefinite-delivery/indefinite-quantity (IDIQ) vehicles and task order competitions designed to foster competition and technical excellence. Belt’s procurement approach reflects a strong preference for open competition, with 92.3% of awards issued without set-aside restrictions. However, he actively supports socioeconomic programs, allocating 5.1% of awards to 8(a) competed contracts and 2.6% to total small business set-asides under FAR 19.5. This balanced strategy prioritizes market access for small businesses while maintaining the technical rigor required for NHLBI’s high-stakes research environment. His primary procurement focus lies in NAICS 334516 (analytical laboratory instrument manufacturing), 541990 (professional scientific services), and 541690 (scientific consulting), reflecting deep expertise in procuring advanced diagnostic equipment, data analytics platforms, and laboratory support services. He frequently sources specialized instrumentation for genomics, proteomics, and clinical trial support, demonstrating a technical command of life sciences procurement and a commitment to acquiring cutting-edge tools that enable scientific discovery.